ABSTRACT Liver regeneration is a very complex and well-orchestrated process associated with signaling cascades involving cytokines, growth factors, and metabolic pathways. Adiponectin is an

adipocytokine secreted by mature adipocytes, and its receptors are widely distributed in many tissues, including the liver. Adiponectin has direct actions in the liver with prominent roles

to improve hepatic insulin sensitivity, increase fatty acid oxidation, and decrease inflammation. To test the hypothesis that adiponectin is required for normal progress of liver

regeneration, 2/3 partial hepatectomy (PH) was performed on wild-type and adiponectin-null mice. Compared to wild-type mice, adiponectin-null mice displayed decreased liver mass regrowth,

cytokine signaling 3 (Socs3) transcription. In conclusion, adiponectin-null mice exhibit impaired liver regeneration and increased hepatic steatosis. Increased expression of Socs3 and

subsequently reduced activation of STAT3 in adiponectin-null mice may contribute to the alteration of the liver regeneration capability and hepatic lipid metabolism after PH. SIMILAR CONTENT

BEING VIEWED BY OTHERS ADIPOR1/ADIPOR2 DUAL AGONIST RECOVERS NONALCOHOLIC STEATOHEPATITIS AND RELATED FIBROSIS VIA ENDOPLASMIC RETICULUM-MITOCHONDRIA AXIS Article Open access 16 November

2020 HEPATIC SERPINA1 IMPROVES ENERGY AND GLUCOSE METABOLISM THROUGH REGULATION OF PREADIPOCYTE PROLIFERATION AND UCP1 EXPRESSION Article Open access 12 November 2024 HEPATOCYTE-SPECIFIC

GDF15 OVEREXPRESSION IMPROVES HIGH-FAT DIET-INDUCED OBESITY AND HEPATIC STEATOSIS IN MICE VIA HEPATIC FGF21 INDUCTION Article Open access 14 October 2024 MAIN The liver has a central role in

metabolic homeostasis, as it is responsible for the metabolism, synthesis, storage, and redistribution of nutrients, carbohydrates, fats, and vitamins. Paradoxically, it is also the main

detoxifying organ of the body, which is frequently challenged by chemical, traumatic, or infectious injuries. Consequently, the liver has evolved a unique ability to regenerate in respond to

liver mass loss because of injuries.1, 2 Liver regeneration, which is driven by the replication of existing hepatocytes, is a process of compensatory hyperplasia rather than a

differentiation process of stem cells.3 One of the most effective models for studying liver regeneration after hepatocellular loss is partial hepatectomy (PH) in rodents. This technique,

which was first described by Higgins and Anderson and performed in rats,4 can be modified to be safely and reproducibly performed in mice.5 After PH, resection of about 2/3 of liver mass

results in quiescent hepatocytes rapidly re-entering the cell cycle. This highly regulated process is primed by different cytokines and growth factors that activate the downstream kinases

and transcription factors. As a result, the hepatocytes initiate the transcription of more than 100 early genes, accumulate triglyceride and cholesterol to supply the energy and materials

required for restore the liver mass. After one or two rounds of replication of hepatocytes, the original liver mass is restored within 5–7 days. Thus, liver regeneration constitutes a unique

model to study signal transduction, lipid metabolism, and cell cycle events in a synchronized manner _in vivo_.2, 3 Adipocytokines are soluble mediators mainly produced by adipocytes. They

influence energy homeostasis and regulate neuroendocrine function as hormones; in addition, they affect immune functions and inflammatory processes as cytokines. Adiponectin (also known as

APN, Acrp30, and GBP28) and leptin are the two most abundant adipocytokines produced by adipocytes. Adiponectin is decreased with obesity and is involved in many obesity-related metabolic

disorders, such as insulin resistance, atherosclerosis, and fatty liver disease.6, 7 Adiponectin interacts with at least two known cellular receptors (AdipoR1 and AdipoR2), which are both

expressed in the liver. Binding of adiponectin to AdipoR1 and/or AdipoR2 stimulates the activation of peroxisome proliferator-activated receptor-_α_ (PPAR_α_) and AMP-activated protein

kinase (AMPK).8, 9 Disruption of PPAR_α_-mediated lipid signaling pathway delays the initiation of liver regeneration.10 Activation of AMPK stimulates _β_-oxidation to influence the lipid

metabolism in hepatocytes.11 The first discovered adipocytokine, leptin, has been proved to be crucial during liver regeneration,12, 13 but whether adiponectin is required during liver

regeneration is still unknown. In addition, many evidences have proved that adiponectin has protective effects on many experimentally induced liver diseases.14, 15, 16 Taken together, we

hypothesized that adiponectin plays a role in liver regeneration. To test this hypothesis, we studied the regeneration process triggered by PH in the liver of adiponectin knockout mice. Our

results showed that adiponectin plays an essential role during liver regeneration. MATERIALS AND METHODS ANIMAL STUDIES All the following studies were approved by the Animal Use and Care

Committee of Shanghai Jiao Tong University School of Medicine. Adiponectin knockout and wild-type mice maintained in a 129S1 background were kept on 12-h dark–light cycles and maintained on

standard mouse chow and water before and after surgery.17 PH was performed on 8–12-weeks-old male mice as described earlier.5 Briefly, animals 8–12 weeks of age were anesthetized by

pentobarbital. The three most anterior liver lobes (right upper, left upper, and left lower lobes), totaling about 68% of the liver, were tied at the origins of the lobes with three knots

and then resected. The peritoneum was re-approximated with a running suture and then the skin was closed. Sterile saline (1 ml) was administered subcutaneously on the back after closing the

abdomen to replace fluid loss from the surgery. Mice were placed under warming lights for at least 1 h after surgery. All the surgeries were performed between 9:00 am and 12:00 pm by one

person. At least four animals in each cohort were killed at each time point analyzed. For determination of total hepatocyte proliferation, BrdU (Sigma, St. Louis, MO, USA) was continuously

given in drinking water to the mice after surgery. In another set of experiments, BrdU was injected intraperitoneally 1 h before killing as described earlier.18 At the time of killing, mice

were anesthetized, and the remaining liver lobes were removed and weighed. For protein and RNA analysis, liver lobes were frozen in liquid nitrogen, and stored at −80°C until use. For

histological analysis, liver lobes were fixed in 10% formalin then embedded in paraffin, or soaked in 30% sucrose (in PBS) at 4°C overnight then frozen in OCT Compound (Sakura Finetek,

Torrance, CA, USA). CELL CULTURE Human hepatoma, HepG2, cells were cultured in DMEM supplemented with 10% FBS (Invitrogen, Carlsbad, CA, USA). HepG2 cells were serum starved overnight, then

treated with or without recombinant human adiponectin (A kind gift from Dr Yan Chen, 10 _μ_g/ml) and leukemia inhibitory factor (LIF) (Chemicon, Temecula, CA, USA, 0.1 _μ_g/ml) for 1 h.

Total RNA was isolated using the TRIzol reagent (Invitrogen). LIVER HISTOLOGY AND IMMUNOHISTOCHEMICAL STAININGS Liver morphology was assessed based on 5-_μ_m hematoxylin and eosin-stained

paraffin sections. To assess the number of hepatocyte mitoses, 30 high-power microscope fields ( × 400) from different liver sections for each sample were counted; counts were expressed as

mitotic figures/10 high-power fields. Hepatocyte nuclear staining for BrdU was performed with primary BrdU antibody (sc-56258, Santa-Cruz Biotechnology, Santa Cruz, CA, USA) using the

commercial kits (Santa-Cruz Biotechnology). Total BrdU-labeled hepatocytes were determined by counting positively stained hepatocyte nuclei in 10 high-power microscope fields ( × 400) per

liver. The cell proliferation index was calculated by dividing the number of labeled hepatocyte nuclei by the total number of hepatocyte nuclei counted, and the results were expressed as a

percentage. Sections of liver frozen in OCT compound (Sakura Finetek) were stained with Oil Red O (Amresco, Solon, OH, USA) for analysis of hepatic fat accumulation. LIVER LIPID CONTENT

Liver triglyceride and cholesterol were extracted as described earlier.19, 20 Triglyceride and cholesterol levels were then measured using the Beckman-Coulter Synchron DxC800 chemistry

analyzers (Fullerton, CA, USA) according to the manufacturer's instruction. QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTION PCR Differential gene expression was detected by quantitative

real-time reverse transcription PCR. Total RNA was isolated from frozen liver tissue using the TRIzol reagent according to the manufacturer's protocol (Invitrogen). DNase I-treated

(Promega, Madison, WI, USA) total liver RNA was reverse transcribed using AMV reverse transcriptase (Takara, Otsu, Japan). cDNA were reverse transcripted, respectively, and then the cDNA of

the four mice with the same genotype in the same time point were mixed equally. PCR reaction mixes were assembled using the SYBR Green real-time PCR Master Mix (Toyobo, Osaka, Japan). The

reactions were performed on the 7900HT Sequence Detection Quantitative PCR System (Applied Biosystems, Foster City, CA, USA). Cycling parameters were 95°C for 3 min and then 40 cycles of

95°C (25 s), 58°C (25 s), and 72°C (25 s) followed by a melting curve analysis. All reactions were performed with four technical replicates and repeated independently for three times. The

cycle threshold values were normalized to the expression of the housekeeping gene _β_-actin. Primer sequences are available in Table 1. WESTERN BLOTTING Frozen liver tissue was homogenized

in RIPA buffer containing Protease Inhibitor Cocktail (Sigma) and PMSF with a homogenizer and a sonicator at 4°C. After centrifuging at 10 000 _g_ for 10 min at 4°C, the supernatant protein

was quantified by the Bio-Rad DC Protein Assay (Hercules, CA, USA). Liver homogenates (50 _μ_g) were separated by SDS–PAGE and were transferred to the nitrocellulose membrane as referred by

the manufacturer's protocols. Antibodies of STAT3 (BD, Franklin Lakes, NJ, USA), phosphor-STAT3 (Tyr705) (Cell Signaling Technology, Danvers, MA, USA), and _β_-actin (Sigma) were used

as probes. HRP-conjugated secondary antibodies were from Kirkegaard & Perry Laboratories (Gaithersburg, MD, USA). Immune complexes were detected using the enhanced chemiluminescence

system (Pierce, Rockford, IL, USA). STATISTICAL ANALYSIS Quantitative data are expressed as mean±s.d. Statistical significance between any two groups was determined by the two-tailed

Student's _t_-test. _P_ values less than 0.05 were considered significant. RESULTS THE EFFECT OF ADIPONECTIN DEFICIENCY ON LIVER MASS RESTORATION AND HEPATOCYTE PROLIFERATION To test

the hypothesis that adiponectin is required for liver regeneration _in vivo_, we induced liver regeneration by performing PH on male wild-type and adiponectin-null mice. Mice were killed and

analyzed during the first 96 h after surgery. Before PH, there was no significant difference in the liver/body weight ratio between wild-type and adiponectin-null mice. However, the

liver/body weight ratio was persistently lower in adiponectin-null mice from 24 to 96 h after PH (Figure 1a). During liver regeneration after PH, the restore of liver mass is predominantly

contributed by proliferation of the hepatocytes. To examine whether adiponectin deficiency causes an impairment of hepatocyte proliferation, wild-type and adiponectin-null mice were

continuously labeled with BrdU and killed at 72 and 96 h after PH. Adiponectin-null mice showed significantly decreased proliferation than wild-type mice (Figure 1b). These results

demonstrate that liver regeneration is impaired in adiponectin-null mice. The peak of hepatocyte proliferation appears between 24 and 48 h after PH.2, 3 We assessed the kinetics of

hepatocyte proliferation during liver regeneration in wild-type and adiponectin-null mice by evaluating hepatocyte DNA synthesis (BrdU pulse labeling) and counting mitotic hepatocytes after

PH. In wild-type mice, the proliferation index (percentage of BrdU-positive hepatocytes) markedly increased at 36 h post PH, reached a peak at 48 h post PH, then decreased to a low level at

72 h post PH. Nevertheless, in adiponectin-null mice, the proliferation index was persistently lower from 36 to 60 h post PH and a little higher at 72 h post PH (Figure 1c and d). The

mitotic figures of hepatocytes were counted and we found that much more mitotic figures were observed at 48 and 60 h post PH in the liver of wild-type mice in comparison with the

adiponectin-null mice (Figure 1e and f). HE staining of liver tissue sections also revealed that both of the wild-type and adiponectin-null livers had increased vacuolation after PH.

However, the vacuolation level, which may represent the hepatic steatosis (lipid accumulation), in adiponectin-null mice was obviously higher than that in the wild-type mice at 48 h post PH.

Hepatic steatosis and focal liver injury were more prominent in the adiponectin-null mice (Figure 1f). We also evaluated the apoptosis level in the livers of both wild- type and

adiponectin-null mice at 48 h post PH using the TUNEL staining, but no significant difference was found (data not shown). Taken together, these results clearly show that the hepatocyte

proliferation of adiponectin-null mice is impeded during the regeneration after PH. THE EFFECT OF ADIPONECTIN DEFICIENCY ON HEPATIC LIPID ACCUMULATION AND CATABOLISM DURING LIVER

REGENERATION After PH, transient hepatic steatosis occurs during early liver regeneration. Mice exhibit markedly increased hepatic lipid accumulation at 12–24 h after PH. And the hepatic

lipid was consumed away 24–48 h after PH, which was proposed to serve as an energy and materials source supporting cell proliferation and tissue re-growth.13 However, It is well established

that excessive lipid accumulation in liver exhibits profound impairment of liver regeneration after PH.12, 21, 22, 23, 24, 25 Adiponectin functions as a hormone to stimulate lipid

catabolism.26 It reduces lipid accumulation by inhibiting hepatic lipogenesis and stimulating fatty acid oxidation.14, 27 These reports led us to determine whether adiponectin has effect on

hepatocellular lipid accumulation and catabolism during liver regeneration. The timing and magnitude of hepatic steatosis during liver regeneration after PH were examined by Oil Red O

staining. Compared to wild-type mice, much more fat accumulated in adiponectin-null livers at 24 h post PH (Figure 2a). Moreover, at 48 h post PH, though the hepatocellular lipid decreased

to a low level in wild-type livers, the lipid in adiponectin-null livers was still abundant (Figure 2a). Corresponding biochemical data supported the morphological observation (Figure 2b and

c). Increased hepatic triglyceride and cholesterol accumulation were determined in adiponectin-null mice, whereas the levels of triglyceride and cholesterol in serum were not significantly

different between wild-type and adiponectin-null mice before PH and after PH (Supplementary Figure 1). These results demonstrate that adiponectin plays an essential role in regulating

hepatic lipid homeostasis during liver regeneration. EXPRESSION OF GENES INVOLVED IN LIPID METABOLISM DURING LIVER REGENERATION In an attempt to explore the molecular mechanism underlying

adiponectin-mediated hepatic lipid metabolism during liver regeneration, expression of genes known to be critical in lipogenesis, fatty acid oxidation, and transportation was profiled by

relative quantitative real-time reverse transcription PCR. We found that the mRNA levels of carnitine palmitoyltransferases I (Cpt-I), PPAR_α_, acetyl-CoA-carboxylase 1 (Acc1), fatty acid

synthase (Fas), and Cd36 were changed in the absence of adiponectin in comparison with wild-type mice during liver regeneration. The average hepatic mRNA level of each gene in wild-type

livers at 0 h was set as 1.0, and the hepatic mRNA level of each gene at 24 h after sham operation was set as a control. Cpt-I is a rate-limiting enzyme involved in the transport of

long-chain fatty acids into mitochondrial matrix.28 It has been well demonstrated that adiponectin can increase the activity of Cpt-I to enhance fatty acid oxidation.14 Our data showed that,

at 0, 12, and 24 h after PH, the hepatic Cpt-I mRNA level was higher in wild-type mice than that in adiponectin-null mice. At 48 h post PH, the hepatic Cpt-I mRNA level in adiponectin-null

mice was equal to the level in wild-type mice. At 72 h post PH, the hepatic Cpt-I mRNA level in adiponectin-null mice was about 1.7-fold higher than that in wild-type mice (Figure 3a). These

findings show that, the upregulation of Cpt-I mRNA is delayed in adiponectin-null mice. PPAR_α_, which can be activated by adiponectin, is a critical regulator of hepatic lipid oxidation.29

The hepatic PPAR_α_ mRNA level was higher in wild-type mice at 24 and 48 h after PH but a little lower at 72 h after PH as compared to that in adiponectin-null mice (Figure 3b). Obviously,

the upregulation of PPAR_α_ mRNA expression, which is similar to that of the Cpt-I mRNA expression, is delayed in adiponectin-null mice. Fas is another key enzyme involved in hepatic

lipogenesis. Expression of hepatic Fas is significantly elevated after PH, and adiponectin can suppress the hepatic mRNA expression of this enzyme.14, 28 From 12 to 48 h after PH, the

hepatic Fas mRNA level was consistently higher in adiponectin-null mice compared to wild-type mice. At 48 h post PH, the level of hepatic Fas transcripts was about 2-fold higher in

adiponectin-null mice than that in wild-type mice (Figure 3c). These data demonstrate that adiponectin can suppress the Fas expression to regulate the hepatic lipogenesis during liver

regeneration after PH. Cd36 is a protein responsible for transportation of fatty acids into tissues,30 and adiponectin treatment can markedly downregulate the hepatic expression of Cd36.14

Both before PH and at 24 h after sham operation, adiponectin-null livers expressed higher Cd36 mRNA level than wild-type livers. This observation suggests that adiponectin might control the

basal PPAR_α_ mRNA level. At 24, 48, and 72 h post PH, adiponectin-null livers consistently expressed at about 2-fold higher Cd36 mRNA than wild-type livers (Figure 3d). These data suggest

that PH-induced Cd36 gene expression might be modulated by adiponectin. Acc1 is a lipogenic enzyme known to be suppressed by adiponectin.9, 14 Marked induction of Acc1 gene expression was

seen in both wild-type and adiponectin-null livers at 48 h post PH. However, the level of hepatic Acc1 transcript was 1.6-fold higher in adiponectin-null mice than that in wild-type mice at

this time point (Figure 3e). These data indicate that adiponectin is involved in the regulation of Acc1 gene expression during liver regeneration. THE ADIPONECTIN PROTEIN LEVELS AND MRNA

EXPRESSION OF ADIPORS DURING LIVER REGENERATION To investigate the function status of adiponectin during the process of liver regeneration, we detected the adiponectin protein level and the

expression pattern of adiponectin receptors (AdipoRs). As expected, there were high levels of adiponectin protein in livers of wild-type mice but no adiponectin protein was detected in

livers of adiponectin-null mice at any point in the regeneration process (Figure 4a). Two receptors for adiponectin (AdipoR1 and AdipoR2) have been identified. AdipoR1 is expressed widely in

mice, whereas AdipoR2 is expressed mainly in the liver.8, 9 Interestingly, the hepatic mRNA levels of AdipoR1 and AdipoR2 both increased after PH and reached a peak at 48 h post PH.

Moreover, in the absence of adiponectin, the mRNA levels of AdipoR1 and AdipoR2 were higher than those of wild-type mice at 48 h post PH (Figure 4b). REDUCED HEPATIC STAT3 ACTIVITY IN

ADIPONECTIN-NULL MICE AFTER PH Cytokine signaling pathways are activated after PH. The interleukin-6 (IL-6)-induced JAK–STAT3 pathway is a key cytokine signaling during liver regeneration.

Binding of IL-6 to its receptor (IL-6R), which is associated with two subunits of gp130, stimulates the tyrosine–kinase activity of the Janus-associated kinase (JAK). Activated JAK then

phosphorylates the associated gp130 and STAT3 on a tyrosine residue. STAT3 then homodimerizes and translocates to the nucleus, where it induces transcription of a number of target genes to

promote the liver regeneration.2, 3 Suppressor of cytokine signaling 3 (Socs3) interacts with JAK and blocks JAK–STAT3 pathway to suppress the process of liver regeneration.31, 32 To

evaluate whether absence of adiponectin affects STAT3-mediated signaling during liver regeneration, hepatic functional status of STAT3 was analyzed by western blotting. From 24 to 72 h after

PH, the phosphorylation of STAT3 was obviously reduced in adiponectin-null mice (Figure 5a). Meanwhile, at 24 and 48 h post PH, the Socs3 mRNA levels in the adiponectin-null mice were about

2-fold higher than those in the wild-type mice (Figure 5b). To determine whether Socs3 mRNA levels can be regulated by adiponectin, human hepatoma, HepG2, cells were treated with human

recombinant adiponectin (APN). After APN treatment, the Socs3 mRNA level was reduced by 32.5% in HepG2 cells. The gene expression of Socs3 was acutely induced by LIF treatment,33 and this

induction was reduced by 24.7% on the addition of APN (Figure 5c). These findings suggest that adiponectin can repress the Socs3 gene transcription. For this reason, the reduced STAT3

activation in adiponectin-null mice after PH is partially resulted from the increased Socs3 level. DISCUSSION In this study, we have investigated the role of adiponectin in liver

regeneration after PH. Our results show that adiponectin is required for normal procession of liver regeneration. In clinical situations, obese patients with fatty livers tend to have poor

outcomes after resection or liver transplantation.21, 22, 23 In experimental situations, both genetic-based models and high-fat-diet-induced model proved that preexisting steatosis caused

significant impairment of liver regeneration after PH.12, 24, 25 In addition, the augmented hepatic steatosis after PH coexisted with the defective liver regeneration after PH in mice.10, 34

This phenomenon was observed in adiponectin-null mice as well. These evidences suggest that excessive fat in hepatocytes may harm the normal process of liver regeneration. In the normal

progress of liver regeneration after PH, hepatic lipid homeostasis is complex and exactly regulated.13 In the absence of adiponectin, hepatocytes accumulated much more lipid, and the lipid

could not be consumed away efficiently. Meanwhile, mRNA levels of related lipid metabolism genes consistently changed. In the early phase after PH, mRNA levels of Cpt-I and PPAR_α_ had

increased higher in wild-type mice in comparison with adiponectin-null mice. These adiponectin-dependent changes of gene expression might lead to enhanced lipid _β_-oxidation. Though the

mRNA levels of Cpt-I and PPAR_α_ increased to normal levels and even higher levels later, the lipid _β_-oxidation might be late for the requirement of energy in the adiponectin-null mice.

Moreover, wild-type mice have reduced mRNA levels of Fas, Cd36, and Acc1. These adiponectin-dependent changes of gene expression might suppress the lipid biosynthesis and uptake to modulate

the hepatic lipid homeostasis during the liver regeneration. Taken as a whole, these results suggest that adiponectin-null mice could not catabolize the accumulated hepatocellular lipid

efficiently to fuel the fire for the normal progress of liver regeneration. The reduced STAT3 activity and increased Socs3 mRNA level could also contribute to the augmented hepatic steatosis

in the adiponectin-null mice. The liver-specific STAT3 deficiency mice show reduced hepatocyte DNA synthesis after PH were complicated with obesity and fatty liver.35, 36 In addition,

inhibition of the expression of Socs3 in liver ameliorates hepatic steatosis, and Socs3 enhances the hepatic steatosis by attenuating STAT3 activity.37 Earlier study has shown that IL-6

treatment alleviates hepatic steatosis through enhancing STAT3 activation as well as upregulating PPAR_α_ expression and activity in mice.38 Recently, it has been reported that fructose-fed

rats show impairment of hepatic STAT-3 activation as well as reduction in PPAR_α_ mRNA expression and activity.39 In our study, adiponectin-null mice also showed reduced STAT3 activity and

PPAR_α_ mRNA expression during the early phase of liver regeneration. These results suggest that STAT3 and PPAR_α_ may take part to the regulation of the hepatic lipid accumulation during

liver regeneration. However, the detail mechanisms on the cross talk between these two pathways remain to be demonstrated. Recent studies suggest that adiponectin can activate STAT3 in the

rat hypothalamus and mouse cardiac fibroblasts.40, 41 Our results provide _in vivo_ evidence that adiponectin can stimulate the STAT3 activation in mouse livers after PH, which is

accompanied by reduced Socs3 transcription. Moreover, our results provide _in vitro_ evidence that adiponectin can repress Socs3 transcription. However, we found no significant difference in

serum levels and hepatic expression levels of IL-6 between wild-type and adiponectin-null mice (data not shown), which indicate that the decreased STAT3 phosphorylation during liver

regeneration represents a direct effect of the adiponectin-dependent Socs3 induction. This is, to our knowledge, the first report to demonstrate that adiponectin-mediated repression of Socs3

gene expression can facilitate STAT3 activation. The direct involvement of the adiponectin–AdipoRs signaling in the induction of Socs3 expression and reduction in STAT3 phosphorylation

still requires further investigations. This study also provides evidence that the transcription of AdipoRs is enhanced after PH. Moreover, the mRNA levels of AdipoRs compensatorily increased

in adiponectin-null mice at 48 h post PH. These results suggest that the downstream signaling cascades of AdipoRs triggered by adiponectin are required in the normal progression of liver

regeneration. However, one of the principal downstream signal transduction proteins, AMPK phosphorylation, did not significantly change during liver regeneration in both wild-type and

adiponectin-null mice (data not shown). When we were preparing our manuscript, Hisao Ezaki and colleagues published their work about the effects of adiponectin on liver regeneration after PH

using different mice strain.42 Our study was generally in agreement with their report on the role of adiponectin during liver regeneration after PH. By PH in C57BL/6 mice, they found that

delayed liver regeneration was due to reduced expression of cyclins and impairment of fatty acid oxidation. Our investigation on the 129S1 mice indicated that adiponectin-null mice showed

impaired liver regeneration and abnormal fatty acid metabolism. Moreover, our results described the reduced phosphorylation of STAT3 and increased transcription of Socs3 in adiponectin-null

mice after PH. It has been proved that activation of STAT3 after PH can promote hepatocyte proliferation through enhancing expression of cyclins.36 These evidences collectively showed the

potential mechanisms underlie the actions of adiponectin during liver regeneration (Figure 6). In summary, adiponectin-null mice showed impaired liver regeneration and altered hepatic lipid

accumulation after PH. Increased Socs3 and subsequently blocked STAT3 signaling in adiponectin-null mice may contribute to the alteration of the liver regeneration capability and hepatic

lipid metabolism after PH. Taken together, these results suggest that adiponectin and AdipoRs could be the novel targets to improve liver regeneration in patients with acute or chronic liver

injury. REFERENCES * Michalopoulos GK, DeFrances MC . Liver regeneration. _Science_ 1997;276:60–66. Article  CAS  PubMed  Google Scholar  * Taub R . Liver regeneration: from myth to

mechanism. _Nat Rev Mol Cell Biol_ 2004;5:836–847. Article  CAS  PubMed  Google Scholar  * Fausto N, Campbell JS, Riehle KJ . Liver regeneration. _Hepatology_ 2006;43:S45–S53. Article  CAS 

PubMed  Google Scholar  * Higgins GM, Anderson RM . Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. _Arch Pathol_

1931;12:186–202. Google Scholar  * Greene AK, Puder M . Partial hepatectomy in the mouse: technique and perioperative management. _J Invest Surg_ 2003;16:99–102. Article  PubMed  Google

Scholar  * Arita Y, Kihara S, Ouchi N, _et al_. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. _Biochem Biophys Res Commun_ 1999;257:79–83. Article  CAS 

PubMed  Google Scholar  * Hu E, Liang P, Spiegelman BM . AdipoQ is a novel adipose-specific gene dysregulated in obesity. _J Biol Chem_ 1996;271:10697–10703. Article  CAS  PubMed  Google

Scholar  * Tilg H, Moschen AR . Adipocytokines: mediators linking adipose tissue, inflammation and immunity. _Nat Rev Immunol_ 2006;6:772–783. Article  CAS  PubMed  Google Scholar  *

Yamauchi T, Kamon J, Ito Y, _et al_. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. _Nature_ 2003;423:762–769. Article  CAS  PubMed  Google Scholar  * Anderson

SP, Yoon L, Richard EB, _et al_. Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice. _Hepatology_ 2002;36:544–554. Article  CAS  PubMed  Google Scholar

  * Yamauchi T, Kamon J, Minokoshi Y, _et al_. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. _Nat Med_ 2002;8:1288–1295.

Article  CAS  PubMed  Google Scholar  * Yang SQ, Lin HZ, Mandal AK, _et al_. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic

fatty liver disease pathophysiology. _Hepatology_ 2001;34:694–706. Article  CAS  PubMed  Google Scholar  * Shteyer E, Liao Y, Muglia LJ, _et al_. Disruption of hepatic adipogenesis is

associated with impaired liver regeneration in mice. _Hepatology_ 2004;40:1322–1332. Article  CAS  PubMed  Google Scholar  * Xu A, Wang Y, Keshaw H, _et al_. The fat-derived hormone

adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. _J Clin Invest_ 2003;112:91–100. Article  CAS  PubMed  PubMed Central  Google Scholar  * Kamada Y, Tamura S,

Kiso S, _et al_. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. _Gastroenterology_ 2003;125:1796–1807. Article  CAS  PubMed  Google Scholar  * Masaki T,

Chiba S, Tatsukawa H, _et al_. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. _Hepatology_ 2004;40:177–184. Article  CAS  PubMed  Google

Scholar  * Ren W, LI X, Wang F, _et al_. Generation of adiponectin gene knock-out and lacZ gene knock-in mouse model. _Prog Biochem Biophys_ 2006;33:846–853. CAS  Google Scholar  * Columbano

A, Ledda-Columbano GM, Pibiri M, _et al_. Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. _Hepatology_ 2005;42:1118–1126. Article  CAS 

PubMed  Google Scholar  * Zhou J, Zhai Y, Mu Y, _et al_. A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. _J Biol Chem_

2006;281:15013–15020. Article  CAS  PubMed  Google Scholar  * Ferramosca A, Savy V, Conte L, _et al_. Conjugated linoleic acid and hepatic lipogenesis in mouse: role of the mitochondrial

citrate carrier. _J Lipid Res_ 2006;47:1994–2003. Article  CAS  PubMed  Google Scholar  * Todo S, Demetris AJ, Makowka L, _et al_. Primary nonfunction of hepatic allografts with preexisting

fatty infiltration. _Transplantation_ 1989;47:903–905. Article  CAS  PubMed  PubMed Central  Google Scholar  * D’Alessandro AM, Kalayoglu M, Sollinger HW, _et al_. The predictive value of

donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. _Transplantation_ 1991;51:157–163. Article  PubMed  Google Scholar  * Behrns KE,

Tsiotos GG, DeSouza NF, _et al_. Hepatic steatosis as a potential risk factor for major hepatic resection. _J Gastrointest Surg_ 1998;2:292–298. Article  CAS  PubMed  Google Scholar  *

Yamauchi H, Uetsuka K, Okada T, _et al_. Impaired liver regeneration after partial hepatectomy in db/db mice. _Exp Toxicol Pathol_ 2003;54:281–286. Article  PubMed  Google Scholar  *

DeAngelis RA, Markiewski MM, Taub R, _et al_. A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. _Hepatology_

2005;42:1148–1157. Article  CAS  PubMed  Google Scholar  * Ahima RS . Metabolic actions of adipocyte hormones: focus on adiponectin. _Obesity (Silver Spring)_ 2006;14 (Suppl 1):9S–15S.

Article  CAS  Google Scholar  * Shklyaev S, Aslanidi G, Tennant M, _et al_. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats.

_Proc Natl Acad Sci USA_ 2003;100:14217–14222. Article  CAS  PubMed  PubMed Central  Google Scholar  * Asins G, Rosa JL, Serra D, _et al_. Gene expression of enzymes regulating ketogenesis

and fatty acid metabolism in regenerating rat liver. _Biochem J_ 1994;299 (Pt 1):65–69. Article  CAS  PubMed  PubMed Central  Google Scholar  * Berger J, Moller DE . The mechanisms of action

of PPARs. _Annu Rev Med_ 2002;53:409–435. Article  CAS  PubMed  Google Scholar  * Bonen A, Campbell SE, Benton CR, _et al_. Regulation of fatty acid transport by fatty acid

translocase/CD36. _Proc Nutr Soc_ 2004;63:245–249. Article  CAS  PubMed  Google Scholar  * Riehle KJ, Campbell JS, McMahan RS, _et al_. Regulation of liver regeneration and

hepatocarcinogenesis by suppressor of cytokine signaling 3. _J Exp Med_ 2008;205:91–103. Article  CAS  PubMed  PubMed Central  Google Scholar  * Seki E, Kondo Y, Iimuro Y, _et al_.

Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings. _J Hepatol_ 2008;48:237–245.

Article  CAS  PubMed  Google Scholar  * Auernhammer CJ, Bousquet C, Melmed S . Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter.

_Proc Natl Acad Sci USA_ 1999;96:6964–6969. Article  CAS  PubMed  PubMed Central  Google Scholar  * Beyer TA, Xu W, Teupser D, _et al_. Impaired liver regeneration in Nrf2 knockout mice:

role of ROS-mediated insulin/IGF-1 resistance. _EMBO J_ 2008;27:212–223. Article  CAS  PubMed  Google Scholar  * Inoue H, Ogawa W, Ozaki M, _et al_. Role of STAT-3 in regulation of hepatic

gluconeogenic genes and carbohydrate metabolism _in vivo_. _Nat Med_ 2004;10:168–174. Article  CAS  PubMed  Google Scholar  * Li W, Liang X, Kellendonk C, _et al_. STAT3 contributes to the

mitogenic response of hepatocytes during liver regeneration. _J Biol Chem_ 2002;277:28411–28417. Article  CAS  PubMed  Google Scholar  * Ueki K, Kondo T, Tseng YH, _et al_. Central role of

suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. _Proc Natl Acad Sci USA_ 2004;101:10422–10427. Article  CAS 

PubMed  PubMed Central  Google Scholar  * Hong F, Radaeva S, Pan HN, _et al_. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.

_Hepatology_ 2004;40:933–941. Article  CAS  PubMed  Google Scholar  * Roglans N, Vila L, Farre M, _et al_. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in

fructose-fed rats. _Hepatology_ 2007;45:778–788. Article  CAS  PubMed  Google Scholar  * Coope A, Milanski M, Araujo EP, _et al_. AdipoR1 mediates the anorexigenic and insulin/leptin-like

actions of adiponectin in the hypothalamus. _FEBS Lett_ 2008;582:1471–1476. Article  CAS  PubMed  Google Scholar  * Liao W, Yu C, Wen J, _et al_. Adiponectin induces interleukin-6 production

and activates STAT3 in adult mouse cardiac fibroblasts. _Biol Cell_ 2009;101:263–272. Article  CAS  PubMed  Google Scholar  * Ezaki H, Yoshida Y, Saji Y, _et al_. Delayed liver regeneration

after partial hepatectomy in adiponectin knockout mice. _Biochem Biophys Res Commun_ 2009;378:68–72. Article  CAS  PubMed  Google Scholar  Download references ACKNOWLEDGEMENTS We thank Dr

Jian Guan from Sixth People's Hospital of Shanghai Jiaotong University and Ying Wang from Institute of Health Sciences for technical assistance in partial hepatechtomy; Dr Yan Chen from

Institute of Nutritional Sciences for providing recombinant human adiponectin protein; Dr Yi-Shi Fan from Clinical laboratory of Ruijin Hospital of Shanghai Jiaotong University for

assistance in triglyceride and cholesterol levels measurement. This work is partially supported by the grants from the National Natural Science Foundation of China (30470951, 39925023,

30530390), the Ministry of Science and Technology of China (2006BAI23B02), the Ministry of Education of China (00TPJS111), and by grants from the Science and Technology Commission of

Shanghai Municipality (07DZ22929, 06DZ05907), and E-Institutes of Shanghai Municipal Education Commission (E03003). AUTHOR INFORMATION Author notes * Run-Zhe Shu and Feng Zhang: These

authors contributed equally to this work. AUTHORS AND AFFILIATIONS * Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese

Academy of Sciences, Shanghai Jiaotong University School of Medicine, Shanghai, China Run-Zhe Shu, Feng Zhang, De-Chun Feng & Zhu-Gang Wang * Department of Medical Genetics, E-Institutes

of Shanghai Universities, Shanghai Jiao Tong University School of Medicine, Shanghai, China Fang Wang, Xi-Hua Li, Wei-Hua Ren, Xiao-Lin Wu, Xue Yang, Xiao-Dong Liao, Lei Huang & 

Zhu-Gang Wang * Shanghai Research Center for Model Organisms, Shanghai, China Wei-Hua Ren & Zhu-Gang Wang * Graduate School of Chinese Academy of Sciences, Shanghai, China Run-Zhe Shu, 

Feng Zhang & De-Chun Feng Authors * Run-Zhe Shu View author publications You can also search for this author inPubMed Google Scholar * Feng Zhang View author publications You can also

search for this author inPubMed Google Scholar * Fang Wang View author publications You can also search for this author inPubMed Google Scholar * De-Chun Feng View author publications You

can also search for this author inPubMed Google Scholar * Xi-Hua Li View author publications You can also search for this author inPubMed Google Scholar * Wei-Hua Ren View author

publications You can also search for this author inPubMed Google Scholar * Xiao-Lin Wu View author publications You can also search for this author inPubMed Google Scholar * Xue Yang View

author publications You can also search for this author inPubMed Google Scholar * Xiao-Dong Liao View author publications You can also search for this author inPubMed Google Scholar * Lei

Huang View author publications You can also search for this author inPubMed Google Scholar * Zhu-Gang Wang View author publications You can also search for this author inPubMed Google

Scholar CORRESPONDING AUTHOR Correspondence to Zhu-Gang Wang. ADDITIONAL INFORMATION DISCLOSURE/CONFLICT OF INTEREST The authors declare no conflict of interest. Supplementary Information

accompanies the paper on the _Laboratory Investigation_ website (http://www.laboratoryinvestigation.org) SUPPLEMENTARY INFORMATION SUPPLEMENTARY FIGURE 1 (JPG 131 KB) RIGHTS AND PERMISSIONS

Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Shu, RZ., Zhang, F., Wang, F. _et al._ Adiponectin deficiency impairs liver regeneration through attenuating STAT3

phosphorylation in mice. _Lab Invest_ 89, 1043–1052 (2009). https://doi.org/10.1038/labinvest.2009.63 Download citation * Received: 16 January 2009 * Revised: 18 April 2009 * Accepted: 08

May 2009 * Published: 29 June 2009 * Issue Date: September 2009 * DOI: https://doi.org/10.1038/labinvest.2009.63 SHARE THIS ARTICLE Anyone you share the following link with will be able to

read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing

initiative KEYWORDS * cell proliferation * hepatic steatosis * knockout mice * partial hepatectomy * Socs3 * STAT3 * PPAR_α_